• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在免疫缺陷小鼠中模拟慢性髓性白血病揭示了异常肥大细胞的扩增和前B细胞的积累。

Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells.

作者信息

Askmyr M, Ågerstam H, Lilljebjörn H, Hansen N, Karlsson C, von Palffy S, Landberg N, Högberg C, Lassen C, Rissler M, Richter J, Ehinger M, Järås M, Fioretos T

机构信息

Department of Clinical Genetics, University and Regional Laboratories, Lund University Hospital, Lund University, Lund, Sweden.

Department of Molecular Medicine and Gene Therapy, Lund University and Department of Hematology and Vascular Disorders, Skåne University Hospital, Lund, Sweden.

出版信息

Blood Cancer J. 2014 Dec 12;4(12):e269. doi: 10.1038/bcj.2014.89.

DOI:10.1038/bcj.2014.89
PMID:25501026
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4315895/
Abstract

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm that, if not treated, will progress into blast crisis (BC) of either myeloid or B lymphoid phenotype. The BCR-ABL1 fusion gene, encoding a constitutively active tyrosine kinase, is thought to be sufficient to cause chronic phase (CP) CML, whereas additional genetic lesions are needed for progression into CML BC. To generate a humanized CML model, we retrovirally expressed BCR-ABL1 in the cord blood CD34(+) cells and transplanted these into NOD-SCID (non-obese diabetic/severe-combined immunodeficient) interleukin-2-receptor γ-deficient mice. In primary mice, BCR-ABL1 expression induced an inflammatory-like state in the bone marrow and spleen, and mast cells were the only myeloid lineage specifically expanded by BCR-ABL1. Upon secondary transplantation, the pronounced inflammatory phenotype was lost and mainly human mast cells and macrophages were found in the bone marrow. Moreover, a striking block at the pre-B-cell stage was observed in primary mice, resulting in an accumulation of pre-B cells. A similar block in B-cell differentiation could be confirmed in primary cells from CML patients. Hence, this humanized mouse model of CML reveals previously unexplored features of CP CML and should be useful for further studies to understand the disease pathogenesis of CML.

摘要

慢性髓性白血病(CML)是一种骨髓增殖性肿瘤,如果不进行治疗,将进展为髓系或B淋巴系表型的急变期(BC)。编码组成型活性酪氨酸激酶的BCR-ABL1融合基因被认为足以导致慢性期(CP)CML,而进展为CML BC则需要额外的基因损伤。为了生成人源化CML模型,我们通过逆转录病毒在脐血CD34(+)细胞中表达BCR-ABL1,并将这些细胞移植到NOD-SCID(非肥胖糖尿病/严重联合免疫缺陷)白细胞介素-2受体γ缺陷小鼠体内。在初代小鼠中,BCR-ABL1表达在骨髓和脾脏中诱导了一种炎症样状态,肥大细胞是唯一被BCR-ABL1特异性扩增的髓系谱系。二次移植后,明显的炎症表型消失,骨髓中主要发现人肥大细胞和巨噬细胞。此外,在初代小鼠中观察到前B细胞阶段存在显著阻滞,导致前B细胞积累。在CML患者的原代细胞中也可以证实B细胞分化存在类似阻滞。因此,这种CML人源化小鼠模型揭示了CP CML以前未被探索的特征,应该有助于进一步研究以了解CML的疾病发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e4/4315895/d5784c986fc6/bcj201489f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e4/4315895/3735f5389199/bcj201489f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e4/4315895/1768317c7f9a/bcj201489f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e4/4315895/47d7b0cec25f/bcj201489f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e4/4315895/d2a120cf6254/bcj201489f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e4/4315895/8a00df3125c6/bcj201489f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e4/4315895/6757a8879802/bcj201489f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e4/4315895/d5784c986fc6/bcj201489f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e4/4315895/3735f5389199/bcj201489f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e4/4315895/1768317c7f9a/bcj201489f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e4/4315895/47d7b0cec25f/bcj201489f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e4/4315895/d2a120cf6254/bcj201489f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e4/4315895/8a00df3125c6/bcj201489f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e4/4315895/6757a8879802/bcj201489f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3e4/4315895/d5784c986fc6/bcj201489f7.jpg

相似文献

1
Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells.在免疫缺陷小鼠中模拟慢性髓性白血病揭示了异常肥大细胞的扩增和前B细胞的积累。
Blood Cancer J. 2014 Dec 12;4(12):e269. doi: 10.1038/bcj.2014.89.
2
RAG enhances BCR-ABL1-positive leukemic cell growth through its endonuclease activity in vitro and in vivo.RAG通过其核酸内切酶活性在体外和体内增强BCR-ABL1阳性白血病细胞的生长。
Cancer Sci. 2021 Jul;112(7):2679-2691. doi: 10.1111/cas.14939. Epub 2021 May 18.
3
The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biology.慢性粒细胞白血病细胞在非肥胖糖尿病/严重联合免疫缺陷小鼠体内的植入动力学和程度反映了供体疾病的阶段:慢性粒细胞白血病生物学的体内模型。
Blood. 1998 Aug 15;92(4):1390-6.
4
Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells.人细胞因子在免疫缺陷小鼠中的转基因表达并不能促进BCR-ABL1转导的人脐带血细胞的髓系扩增。
PLoS One. 2017 Oct 12;12(10):e0186035. doi: 10.1371/journal.pone.0186035. eCollection 2017.
5
SHP2 is required for BCR-ABL1-induced hematologic neoplasia.SHP2 对于 BCR-ABL1 诱导的血液肿瘤发生是必需的。
Leukemia. 2018 Jan;32(1):203-213. doi: 10.1038/leu.2017.250. Epub 2017 Aug 14.
6
High frequency of BTG1 deletions in patients with BCR-ABL1-positive acute leukemia.BCR-ABL1阳性急性白血病患者中BTG1缺失的高频率。
Cancer Genet. 2014 May;207(5):226-30. doi: 10.1016/j.cancergen.2014.05.003. Epub 2014 May 16.
7
Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.SPA-1在小鼠模型中由表达BCR-ABL的造血祖细胞诱导的慢性粒细胞白血病表型中的作用。
Cancer Res. 2006 Oct 15;66(20):9967-76. doi: 10.1158/0008-5472.CAN-06-1346.
8
Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.与v-Abl相比,Bcr-Abl具有更强的内在能力来诱导髓系细胞的肿瘤性增殖。
Oncogene. 2000 Dec 14;19(54):6286-96. doi: 10.1038/sj.onc.1204023.
9
Establishment of a new Glivec-resistant chronic myeloid leukemia cell line, SNUCML-02, using an in vivo model.采用体内模型建立新的 Glivec 耐药慢性髓系白血病细胞系 SNUCML-02。
Exp Hematol. 2010 Sep;38(9):773-81. doi: 10.1016/j.exphem.2010.04.012. Epub 2010 May 21.
10
Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis.在BCR-ABL白血病发生的转基因模型中,伴有造血干细胞扩增的髓系白血病可诱导慢性期。
Blood. 2005 Jan 1;105(1):324-34. doi: 10.1182/blood-2003-12-4369. Epub 2004 Aug 26.

引用本文的文献

1
Integrated multi-omics characterization across clinically relevant subgroups of long COVID.长新冠临床相关亚组的综合多组学特征分析
Natl Sci Rev. 2024 Nov 15;12(8):nwae410. doi: 10.1093/nsr/nwae410. eCollection 2025 Aug.
2
Editorial: New strategies for reversing cancer therapy resistance.社论:逆转癌症治疗耐药性的新策略
Front Pharmacol. 2024 Apr 18;15:1411519. doi: 10.3389/fphar.2024.1411519. eCollection 2024.
3
Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy.

本文引用的文献

1
Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts.显性负性 Ikaros 与 BCR-ABL1 协同诱导异种移植中的人急性髓系白血病。
Leukemia. 2015 Jan;29(1):177-87. doi: 10.1038/leu.2014.150. Epub 2014 May 5.
2
Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene.BCR-ABL1 融合基因对慢性髓性白血病患者原始间充质前体细胞和造血骨髓细胞的影响。
Am J Hematol. 2014 Mar;89(3):288-94. doi: 10.1002/ajh.23626.
3
BCR-ABL-induced deregulation of the IL-33/ST2 pathway in CD34+ progenitors from chronic myeloid leukemia patients.
在构建用于研究人类血液系统恶性肿瘤发病机制和免疫治疗的小鼠模型方面的进展。
Front Immunol. 2023 Aug 14;14:1195194. doi: 10.3389/fimmu.2023.1195194. eCollection 2023.
4
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model.骨髓肥大细胞缺失可预防 CML 小鼠模型中 BCR::ABL1 诱导的脾肿大和细胞因子升高。
Leukemia. 2023 Jul;37(7):1474-1484. doi: 10.1038/s41375-023-01916-x. Epub 2023 May 9.
5
Increased number of mast cells in the bone marrow of chronic myeloid leukemia may herald the pending myeloid transformation-the mast cell is an indicator of myeloid transformation.慢性髓系白血病患者骨髓中肥大细胞数量增加可能预示着即将发生的髓系转化——肥大细胞是髓系转化的一个指标。
Transl Cancer Res. 2019 Sep;8(5):2121-2129. doi: 10.21037/tcr.2019.09.29.
6
B-Lymphoid Blast Phase of Chronic Myeloid Leukemia: A Case Report and Review of the Literature.慢性髓性白血病的B淋巴细胞母细胞期:一例报告并文献复习
AJSP Rev Rep. 2019 Sep-Oct;24(5):191-195.
7
Dasatinib regulates LPS-induced microglial and astrocytic neuroinflammatory responses by inhibiting AKT/STAT3 signaling.达沙替尼通过抑制 AKT/STAT3 信号通路调节 LPS 诱导的小胶质细胞和星形胶质细胞神经炎症反应。
J Neuroinflammation. 2019 Oct 26;16(1):190. doi: 10.1186/s12974-019-1561-x.
8
Humanized mouse models of genetic immune disorders and hematological malignancies.遗传免疫性疾病和血液系统恶性肿瘤的人源化小鼠模型。
Biochem Pharmacol. 2020 Apr;174:113671. doi: 10.1016/j.bcp.2019.113671. Epub 2019 Oct 18.
9
Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells.人细胞因子在免疫缺陷小鼠中的转基因表达并不能促进BCR-ABL1转导的人脐带血细胞的髓系扩增。
PLoS One. 2017 Oct 12;12(10):e0186035. doi: 10.1371/journal.pone.0186035. eCollection 2017.
10
The SCLtTAxBCR-ABL transgenic mouse model closely reflects the differential effects of dasatinib on normal and malignant hematopoiesis in chronic phase-CML patients.SCLtTAxBCR-ABL转基因小鼠模型密切反映了达沙替尼对慢性期慢性粒细胞白血病患者正常和恶性造血的不同影响。
Oncotarget. 2017 May 23;8(21):34736-34749. doi: 10.18632/oncotarget.16152.
BCR-ABL 诱导慢性髓性白血病患者 CD34+祖细胞中 IL-33/ST2 通路的失调。
Cancer Res. 2014 May 15;74(10):2669-76. doi: 10.1158/0008-5472.CAN-13-2797. Epub 2014 Mar 27.
4
The IL-2/CD25 axis maintains distinct subsets of chronic myeloid leukemia-initiating cells.IL-2/CD25 轴维持慢性髓性白血病起始细胞的不同亚群。
Blood. 2014 Apr 17;123(16):2540-9. doi: 10.1182/blood-2013-07-517847. Epub 2014 Feb 26.
5
RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.RNA测序鉴定出白血病中与临床相关的融合基因,包括一种对伊马替尼有反应的新型MEF2D/CSF1R融合基因。
Leukemia. 2014 Apr;28(4):977-9. doi: 10.1038/leu.2013.324. Epub 2013 Nov 4.
6
Differential regulation of myeloid leukemias by the bone marrow microenvironment.骨髓微环境对髓性白血病的差异调控。
Nat Med. 2013 Nov;19(11):1513-7. doi: 10.1038/nm.3364. Epub 2013 Oct 27.
7
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.TopHat2:在存在插入、缺失和基因融合的情况下对转录组进行精确比对。
Genome Biol. 2013 Apr 25;14(4):R36. doi: 10.1186/gb-2013-14-4-r36.
8
How I treat CML blast crisis.我如何治疗 CML 急变期。
Blood. 2012 Jul 26;120(4):737-47. doi: 10.1182/blood-2012-03-380147. Epub 2012 May 31.
9
Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia.慢性髓性白血病中白血病和正常干细胞的微环境调节改变。
Cancer Cell. 2012 Apr 17;21(4):577-92. doi: 10.1016/j.ccr.2012.02.018.
10
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity.尽管抑制了 BCR-ABL 活性,但人类慢性髓系白血病干细胞对伊马替尼不敏感。
J Clin Invest. 2011 Jan;121(1):396-409. doi: 10.1172/JCI35721. Epub 2010 Dec 13.